Get the Stockscreener App
6.45
3.44%
-0.23
After Hours:
6.45
Immatics N V stock is traded at $6.45, with a volume of 547.14K.
It is down -3.44% in the last 24 hours and up +19.89% over the past month.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$6.68
Open:
$6.68
24h Volume:
547.14K
Relative Volume:
0.92
Market Cap:
$784.00M
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-4.9627
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
+0.00%
1M Performance:
+19.89%
6M Performance:
+17.92%
1Y Performance:
-46.34%
1-Day Range:
$6.30
$6.75
1-Week Range:
$6.2305
$6.8025
52-Week Range:
$3.30
$13.09
Immatics N V Stock (IMTX) Company Profile
Compare IMTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
6.45 | 811.96M | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
Does Immatics N.V. Equity Warrant qualify in momentum factor screeningInvestment Timeline and ROI Summary Report - Newser
What are Immatics N.V. company’s key revenue driversRetirement Planning Target Finder Backed By Experts - jammulinksnews.com
Is Immatics N.V. a growth stock or a value stockBreakout Stocks Signals For Fast Growth - jammulinksnews.com
How does Immatics N.V. generate profit in a changing economyStock Market Guidance With High Returns - jammulinksnews.com
Is Immatics N.V. building a consolidation basePredictable Income Summary for Long-Term Trades - Newser
Published on: 2025-07-30 23:50:40 - metal.it
Immatics N.V. Equity Warrant stock daily chart insightsRisk-Managed Strategy Based on Price Analysis - Newser
What makes Immatics N.V. Equity Warrant stock price move sharplyGrowth Projection Summary for Long-Term Investors - Newser
How to forecast Immatics N.V. trends using time seriesIntraday Price Forecast Using Volume Models - Newser
Why Immatics N.V. Equity Warrant stock attracts strong analyst attentionFree Reliable Chart-Based Trade Entries - Newser
Immatics N.V. Stock Approaches Key Moving AverageHigh Accuracy Alerts for ROI Traders Detected - metal.it
What machine learning models say about Immatics N.V. Equity WarrantTrade Alert System with Volume Analysis - Newser
Immatics N.V. Stock Support and Resistance Levels You Should KnowSecure Capital Picks With Upside Potential Tracked - metal.it
What high frequency data says about Immatics N.V.Free Long Hold Safe Return Strategy - Newser
Why Immatics N.V. stock attracts strong analyst attentionSector Rotation Strategy for Smart Traders - Newser
Detecting support and resistance levels for Immatics N.V.Portfolio Allocation Strategy for Stability - Newser
Quant Tools Rank Immatics N.V. as High Risk High RewardBuy Signal Based on Chart Analysis Confirmed - metal.it
Is Immatics N.V. stock overvalued or undervaluedRetirement Planning Guidance To Watch Now - jammulinksnews.com
Immatics N.V. Breakout Confirmed by Volume MetricsPrice Action Based Buy Opportunity List Published - metal.it
Published on: 2025-07-28 14:12:42 - metal.it
What is the dividend policy of Immatics N.V. stockBuild a portfolio that outperforms the market - jammulinksnews.com
Is it time to cut losses on Immatics N.V.Free Step-by-Step Stock Investment Guide - Newser
Immatics N.V. Stock Chart Analysis: Bullish or Bearish Pattern FormingVerified Return Tips - metal.it
Sectors Driving Future Growth for Immatics N.V. StockBig Profit Small Risk Alerts - metal.it
What are analysts’ price targets for Immatics N.V. in the next 12 monthsSuperior risk-adjusted returns - jammulinksnews.com
Should I hold or sell Immatics N.V. stock in 2025Build a diversified portfolio for maximum returns - jammulinksnews.com
Why is Immatics N.V. stock attracting strong analyst attentionUnlock high-yield investment opportunities - jammulinksnews.com
Why is Immatics N.V. Equity Warrant stock attracting strong analyst attentionGet exclusive access to expert stock recommendations - jammulinksnews.com
When is Immatics N.V. stock expected to show significant growthMarket-crushing stock picks - jammulinksnews.com
What is the risk reward ratio of investing in Immatics N.V. Equity Warrant stockConsistently high yield - jammulinksnews.com
When is Immatics N.V. Equity Warrant stock expected to show significant growthTremendous gains - jammulinksnews.com
Is it the right time to buy Immatics N.V. Equity Warrant stockBuild a portfolio with strong long-term growth - jammulinksnews.com
What makes Immatics N.V. stock price move sharplyMaximize returns with disciplined investment techniques - jammulinksnews.com
Will Immatics N.V. Stock Benefit from AI and Green Energy TrendsMarket Beating Strategy - Newser
What institutional investors are buying Immatics N.V. Equity Warrant stockDouble or triple returns - jammulinksnews.com
Immatics N.V. Equity Warrant Stock Support and Resistance Levels You Should KnowBalanced Risk Reward Portfolio - Newser
How Immatics N.V. Equity Warrant stock performs during market volatilityFree Stock Selection with 300% Return - Newser
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):